{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:33:24Z","timestamp":1777901604102,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":78,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.vph.2025.107529","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T01:01:38Z","timestamp":1755651698000},"page":"107529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evaluation of non-invasive low-risk criteria in patients with connective tissue disease-associated pulmonary arterial hypertension: A 12-months analysis from the INSPECTIO study"],"prefix":"10.1016","volume":"160","author":[{"given":"Livio","family":"Giuliani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"D'Alto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Di Poi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Corda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Piero","family":"Perna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Badagliacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Vicenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Air\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Toma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Scelsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Piccinino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natale Daniele","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo Mario","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Baldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Biancospino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Uglietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"De Santis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vph.2025.107529_bb0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40119-024-00361-w","article-title":"Macitentan in pulmonary arterial hypertension associated with connective tissue disease (CTD-PAH): real-world evidence from the combined OPUS\/OrPHeUS dataset","volume":"13","author":"Channick","year":"2024","journal-title":"Cardiol. Ther."},{"issue":"1","key":"10.1016\/j.vph.2025.107529_bb0010","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.vph.2025.107529_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12276","article-title":"Connective tissue disease-associated pulmonary hypertension: a comprehensive review","volume":"13","author":"Khangoora","year":"2023","journal-title":"Pulm. Circ."},{"issue":"11","key":"10.1016\/j.vph.2025.107529_bb0020","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1007\/s12325-023-02658-z","article-title":"Real-world treatment patterns among patients with connective tissue disorder-related pulmonary arterial hypertension in the United States: a retrospective claims-based analysis","volume":"40","author":"Sargent","year":"2023","journal-title":"Adv. Ther."},{"key":"10.1016\/j.vph.2025.107529_bb0025","article-title":"Recent developments in connective tissue disease associated pulmonary arterial hypertension","volume":"16","author":"Rodolfi","year":"2024","journal-title":"Int. J. Cardiol. Congenit. Heart Dis."},{"issue":"2","key":"10.1016\/j.vph.2025.107529_bb0030","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1378\/chest.11-1460","article-title":"An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL registry","volume":"142","author":"Benza","year":"2012","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.vph.2025.107529_bb0035","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.vph.2025.107529_bb0040","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMoa1503184","article-title":"Selexipag for the treatment of pulmonary arterial hypertension","volume":"373","author":"Sitbon","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.vph.2025.107529_bb0045","doi-asserted-by":"crossref","first-page":"1602493","DOI":"10.1183\/13993003.02493-2016","article-title":"Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension","volume":"50","author":"Gaine","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"Issue Supplement_1","key":"10.1016\/j.vph.2025.107529_bb0050","article-title":"Real-world evidence on pulmonary arterial hypertension: interim analysis from the Italian observational study INSPECTIO","volume":"45","author":"D'Alto","year":"2024","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.vph.2025.107529_bb0055","first-page":"1747","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European league against rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.vph.2025.107529_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.51645\/khj.2024.433","article-title":"Pulmonary hypertension in connective tissue diseases","volume":"27","author":"Soy","year":"2024","journal-title":"Ko\u015fuyolu Heart J."},{"issue":"4","key":"10.1016\/j.vph.2025.107529_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103506","article-title":"Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): recent and advanced data","volume":"23","author":"Thoreau","year":"2024","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.vph.2025.107529_bb0070","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.chest.2017.02.010","article-title":"Idiopathic and systemic sclerosis-associated pulmonary arterial hypertension: a comparison of demographic, hemodynamic, and MRI characteristics and outcomes","volume":"152","author":"Ramjug","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.vph.2025.107529_bb0075","article-title":"Pathologic differences between systemic sclerosis-associated and idiopathic pulmonary arterial hypertension","author":"Friedman","year":"2024","journal-title":"J. Scleroderma. Relat. Disord."},{"issue":"3","key":"10.1016\/j.vph.2025.107529_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12403","article-title":"Selexipag in patients with pulmonary arterial hypertension associated with connective tissue disease (PAH-CTD): real-world experience from EXPOSURE","volume":"14","author":"Gaine","year":"2024","journal-title":"Pulm. Circ."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:58:40Z","timestamp":1766152720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189125000680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":16,"alternative-id":["S1537189125000680"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2025.107529","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of non-invasive low-risk criteria in patients with connective tissue disease-associated pulmonary arterial hypertension: A 12-months analysis from the INSPECTIO study","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2025.107529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107529"}}